1 James Cook University, Cairns, Queensland, Australia.
2 The University of Queensland, Brisbane, Queensland, Australia.
Neurorehabil Neural Repair. 2017 Dec;31(12):1005-1016. doi: 10.1177/1545968317744276. Epub 2017 Dec 4.
Stroke survivors with severe upper limb disability need opportunities to engage in task-oriented practice to achieve meaningful recovery.
To compare the effect of SMART Arm training, with or without outcome-triggered electrical stimulation to usual therapy, on arm function for stroke survivors with severe upper limb disability undergoing inpatient rehabilitation.
A prospective, multicenter, randomized controlled trial was conducted with 3 parallel groups, concealed allocation, assessor blinding and intention-to-treat analysis. Fifty inpatients within 4 months of stroke with severe upper limb disability were randomly allocated to 60 min/d, 5 days a week for 4 weeks of (1) SMART Arm with outcome-triggered electrical stimulation and usual therapy, (2) SMART Arm alone and usual therapy, or (3) usual therapy. Assessment occurred at baseline (0 weeks), posttraining (4 weeks), and follow-up (26 and 52 weeks). The primary outcome measure was Motor Assessment Scale item 6 (MAS6) at posttraining.
All groups demonstrated a statistically ( P < .001) and clinically significant improvement in arm function at posttraining (MAS6 change ≥1 point) and at 52 weeks (MAS6 change ≥2 points). There were no differences in improvement in arm function between groups (P = .367). There were greater odds of a higher MAS6 score in SMART Arm groups as compared with usual therapy alone posttraining (SMART Arm stimulation generalized odds ratio [GenOR] = 1.47, 95%CI = 1.23-1.71) and at 26 weeks (SMART Arm alone GenOR = 1.31, 95% CI = 1.05-1.57).
SMART Arm training supported a clinically significant improvement in arm function, which was similar to usual therapy. All groups maintained gains at 12 months.
上肢严重残疾的脑卒中幸存者需要有机会进行以任务为导向的实践,以实现有意义的康复。
比较 SMART 手臂训练联合或不联合基于结果的电刺激与常规治疗对上肢严重残疾的脑卒中幸存者在住院康复期间的手臂功能的影响。
这是一项前瞻性、多中心、随机对照试验,采用 3 个平行组、隐藏分组、评估者设盲和意向治疗分析。在脑卒中后 4 个月内,将 50 名上肢严重残疾的住院患者随机分配到以下 3 个组:(1)SMART 手臂训练联合基于结果的电刺激和常规治疗;(2)SMART 手臂训练单独联合常规治疗;(3)常规治疗。评估在基线(0 周)、训练后(4 周)和随访(26 周和 52 周)进行。主要结局测量指标是训练后运动评估量表第 6 项(MAS6)。
所有组在训练后(MAS6 改变≥1 分)和 52 周时(MAS6 改变≥2 分)手臂功能均表现出统计学上(P<0.001)和临床上显著的改善。组间手臂功能的改善没有差异(P=0.367)。与单独常规治疗相比,SMART 手臂训练组在训练后(SMART 手臂刺激广义优势比[GenOR]为 1.47,95%CI 为 1.23-1.71)和 26 周时(SMART 手臂单独 GenOR 为 1.31,95%CI 为 1.05-1.57)获得更高 MAS6 评分的可能性更大。
SMART 手臂训练有助于上肢功能的临床显著改善,与常规治疗相似。所有组在 12 个月时都保持了获益。